Free Newsletters - Space - Defense - Environment - Energy - Solar - Nuclear
..
. 24/7 Space News .




CLONE AGE
How stem cell therapy can keep the immune system under control
by Staff Writers
Los Angeles CA (SPX) Apr 30, 2012


File image.

A new study, appearing in Cell Stem Cell and led by researchers at the University of Southern California, outlines the specifics of how autoimmune disorders can be controlled by infusions of mesenchymal stem cells.

Mesenchymal stem cells (MSC) are highly versatile stem cells that originate from the mesoderm, or middle layer of tissue, in a developing embryo. MSC can be isolated from many different kinds of human tissue, including bone marrow and the umbilical cord.

Principal investigator Songtao Shi, professor at the Ostrow School of Dentistry of USC Center for Craniofacial Molecular Biology, said that recent studies have shown the benefits of administering MSC to patients with immune-related disorders such as graft versus host disease, systemic lupus erythematosus, rheumatoid arthritis, and more.

These studies showed that infusions of MSC appeared to quell the production and function of overactive immune cells, including T- and B-lymphocytes. However, the specific mechanism behind how MSC get the immune cells under control hasn't been fully understood.

"Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis" shines light on how infused MSCs target and defeat overactive immune cells.

Examining the effects of MSC infusion in mice with systemic sclerosis (SS)-like immune disorders, Shi and his colleagues discovered that a specific cellular mechanism known as the FAS/FAS-ligand pathway was the key to the remarkable immune system benefits.

Specifically, in mice with SS-like disorders, infusions of MSC caused T-lymphocyte death with FASL/FAS signaling and lessened symptoms of the immune disorder. However, MSC deficient in FAS-ligand failed to treat immune disorders in SS-afflicted mice.

With the hopeful results of the animal model study in mind, Shi's colleagues in China performed a pilot study with patients suffering from systemic sclerosis. Infusions of MSCs provided similar clinical benefits to patients, and experimental analysis revealed that the FASL/FAS pathway was also at work in humans with SS.

The identification of the cellular workings responsible for the stem cell treatments' success may eventually help doctors find optimal cell-based treatment for some immune diseases, Shi said.

Basic research portions of this study were supported by the National Institute of Dental and Craniofacial Research and the California Institute for Regenerative Medicine. Clinical studies were supported by a grant from the China Major International (Regional) Joint Research Project.

.


Related Links
University of Southern California
The Clone Age - Cloning, Stem Cells, Space Medicine






Comment on this article via your Facebook, Yahoo, AOL, Hotmail login.

Share this article via these popular social media networks
del.icio.usdel.icio.us DiggDigg RedditReddit GoogleGoogle




Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News





CLONE AGE
Researchers discover unique suspension technique for large-scale stem cell production
Toronto, Canada (SPX) Apr 13, 2012
Post-doctoral researcher David Fluri and Professor Peter Zandstra at the University of Toronto's Institute of Biomaterials and Biomedical Engineering (IBBME) have developed a unique new technique for growing stem cells that may make possible cost-effective, large-scale stem cell manufacturing and research. Although stem cells are widely used for the testing of new drugs, researchers have a ... read more


CLONE AGE
India's second moon mission Chandrayaan-2 to wait

European Google Lunar X Prize Teams Call For Science Payloads

Russia to Send Manned Mission to Moon by 2030

NASA Contract to Astrobotic Technology Investigates Prospecting for Lunar Resources

CLONE AGE
New form of Mars lava flow dicovered

100 Days and Counting to NASA's Curiosity Mars Rover Landing

Durable NASA Rover Beginning Ninth Year of Mars Work

Surviving the conditions on Mars

CLONE AGE
Space -- the next frontier for Hillary Clinton?

Company to Create 'Gas Stations' in Space

Boeing, NASA Sign Agreement on Mission Support for CST-100

Parachutes for NASA crew capsule tested

CLONE AGE
China's Lunar Docking

Shenzhou-9 may take female astronaut to space

China to launch 100 satellites during 2011-15

Three for Tiangong

CLONE AGE
Expedition 30 Lands in Kazakhstan

Three astronauts to land from ISS Friday

Expedition 30 Crew Returning Home Friday

Russia brings three spacemen safely back to Earth

CLONE AGE
Indian rocket being fuelled for Risat-1 launch

Assembly begins for the third Ariane 5 to be launched in 2012

ILS Proton Successfully Launches Y1B Satellite For Yahsat

SpaceX aims for May 7 launch to ISS

CLONE AGE
Three Earthlike planets identified by Cornell astronomers

Some Stars Capture Rogue Planets

ALMA Reveals Workings of Nearby Planetary System

UF-led team uses new observatory to characterize low-mass planets orbiting nearby star

CLONE AGE
Astrium and Hisdesat to establish radar satellite constellation to improve coverage and access

Microsoft counts on allies in mistimed tablet market

NASA Awards Safety and Mission Assurance Contract to ARES

Apple avoiding billions in global taxes: report




The content herein, unless otherwise known to be public domain, are Copyright 1995-2014 - Space Media Network. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement,agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement